Katayama, Ryohei http://orcid.org/0000-0001-7394-895X
Gong, Bo
Togashi, Noriko http://orcid.org/0000-0003-2606-0231
Miyamoto, Masaya
Kiga, Masaki
Iwasaki, Shiho
Kamai, Yasuki
Tominaga, Yuichi
Takeda, Yasuyuki
Kagoshima, Yoshiko
Shimizu, Yuki
Seto, Yosuke
Oh-hara, Tomoko
Koike, Sumie
Nakao, Naoki
Hanzawa, Hiroyuki
Watanabe, Kengo http://orcid.org/0000-0001-7808-1160
Yoda, Satoshi http://orcid.org/0000-0003-4201-1392
Yanagitani, Noriko
Hata, Aaron N.
Shaw, Alice T.
Nishio, Makoto
Fujita, Naoya
Isoyama, Takeshi http://orcid.org/0000-0002-2894-5773
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP16H04715, JP19H03524, JP15H02368, JP17H06327)
Japan Agency for Medical Research and Development (JP18cm0106203h0003, JP18ck0106231h0003)
Vehicle Racing Commemorative Foundation (N/A)
Nippon Foundation (N/A)
Article History
Received: 14 September 2018
Accepted: 19 July 2019
First Online: 9 August 2019
Competing interests
: R. Katayama reports grants from TAIHO Pharmaceutical, grants from FUJIFILM, grants from TOPPAN Printing, grants from TAKEDA, personal fees from Pfizer, outside the submitted work. N. Yanagitani reports personal fees from Chugai Pharmaceutical, outside the submitted work. A.N. Hata received research grants/funding from: Novartis, Pfizer, Amgen, Roche/Genentech and Relay Therapeutics. A.T. Shaw. has served as a compensated consultant or received honoraria from ARIAD, Bayer, Blueprint Medicines, Chugai, Daiichi Sankyo, EMD Serono, Foundation Medicine, Genentech/Roche, Guardant, Ignyta, KSQ Therapeutics, Loxo, Natera, Novartis, Pfizer, Taiho Pharmaceutical, Takeda, and TP Therapeutics, and has received research (institutional) funding from Daiichi Sankyo, Ignyta, Novartis, Pfizer, Roche/Genentech, and TP Therapeutics. M. Nishio reports grants and personal fees from Ono Pharmaceutical, grants and personal fees from Bristol Myers Squibb, grants and personal fees from Pfizer, grants and personal fees from Chugai Pharmaceutical, grants and personal fees from Eli Lilly, grants and personal fees from Taiho Pharmaceutical, grants and personal fees from AstraZeneca, personal fees from Boehringer–Ingelheim, grants and personal fees from MSD, grants and personal fees from Novartis, personal fees from Sankyo Healthcare, personal fees from Taiho Pharmaceutical, personal fees from Merck Serono, grants from Astellas, outside the submitted work. N. Fujita reports grants from Api Co., Ltd., outside the submitted work. B. Gong., T. Oh-hara, Y. Seto, Y. Shimizu, and S. Koike have nothing to disclose. N. Togashi, M. Miyamoto, M. Kiga, S. Iwasaki, Y. Kamai, Y. Tominaga, Y. Takeda, Y. Kagoshima, K. Watanabe, and T. Isoyama are employees of Daiichi Sankyo Co., Ltd. N. Nakao and H. Hanzawa are employees of Daiichi Sankyo RD Novare Co., Ltd.